Skip to main content
Summary
Profile
Financials
Events
Ownership
Options

Competitors

SymbolLastChange
SRRA16.870.00 (0.00%)
RVNC13.430.00 (0.00%)
REPL20.760.00 (0.00%)
CHRS12.590.00 (0.00%)
VAXX8.160.00 (0.00%)

Company Info

Industry Biotechnology
Sector Health Technology
Employees 69
CEO Dr. Stephen George Dilly
Address 885 West Georgia Street Suite 2150, Vancouver, BC V6C 3E8
Phone 1.604.558.6536
Website www.sierraoncology.com

Sierra Oncology, Inc. is a clinical stage drug development company of therapeutics for the treatment of cancer. The firm focuses on advancing targeted therapeutics for the treatment of patients with significant unmet medical needs in hematology and oncology. Its product Momelotinib, a selective and orally-bioavailable JAK1, JAK2 & ACVR1 inhibitor with a differentiated therapeutic profile in myelofibrosis encompassing robust constitutional symptom improvements. The company was founded on May 8, 2003 and is headquartered in Vancouver, Canada.

Statement Summary

as of 4:00 ET PM 01/20/2022
Total Assets (MRQ) 104.2 M
Total Liabilities (MRQ) 9.2 M
Shareholders’ Equity (MRQ) 95.1 M
Total Revenue (Annual) n/a
Net Income (Annual) -28.6 M

SRRA vs S&P 500

as of 01/20/2022
Relative To
S&P 500
SRRA
4 Weeks n/a n/a
12 Weeks n/a n/a
YTD n/a n/a

Earnings Surprises

as of 4:00 ET PM 01/20/2022
Fiscal Quarter Estimate Actual Surprise
09/2021 -1.88 -2.10 +11.58%
06/2021 -1.62 -1.67 +3.41%
03/2021 -1.61 -1.71 +6.54%
12/2020 -1.52 -1.63 +7.41%
09/2020 -1.64 -1.39 -15.37%
06/2020 -1.63 -1.58 -2.92%
03/2020 -2.74 -3.14 +14.60%
12/2019 -3.17 -7.88 +148.97%

Financial Strength

as of 4:00 ET PM 01/20/2022
Pre-Tax Margin 0.00
Net Margin 0.00
Operating Margin 0.00
Return On Equity -87.03
Return On Assets -80.28
Inventory Turnover (TTM) 0.00
Sales Growth (MRQ) n/a

Ratios

as of 4:00 PM ET 01/20/2022
Price/Earnings (TTM) n/a
Price/Book (MRQ) 2.57
Price/Cash Flow (TTM) 0.00
Book Value (MRQ) 6.56
Quick Ratio (MRQ) 11.91
Current Ratio (MRQ) 11.91
Total Debt/Equity (MRQ) 0.01

Short Interest

as of 4:00 PM ET 01/21/2022
% Short - 0.00%
% Remaining Float - 100.00%
Current Last Month
Short Interest Date n/a n/a
Short Interest Shares 0 0
Short Interest Ratio 0.0 0.0
M Y M Y
Total Assets 0,0.00 0,0.00
Total Liabilities 0,0.00 0,0.00
Total Equity 0,0.00 0,0.00
M Y M Y
Total Revenue 0,0.00 0,0.00
EBT Exc.
Unusual Items
0,0.00 0,0.00
Net Income 0,0.00 0,0.00
M Y M Y
Cash from
Operations
0,0.00 0,0.00
Cash from
Activities
0,0.00 0,0.00
Cash from
Fin. Activities
0,0.00 0,0.00

TOTAL ASSETS

TOTAL LIABILITIES

TOTAL EQUITY

Balance Sheet

M Y
ASSETS
Cash And Equivalents 0,0.00
Receivables 0,0.00
Inventories 0,0.00
Other Current Assets 0,0.00
Total Current Assets 0,0.00
Property, Plant & Equipment, Gross 0,0.00
Accumulated Depreciation & Depletion 0,0.00
Property, Plant & Equipment, Net 0,0.00
Intangibles 0,0.00
Other Non-Current Assets 0,0.00
Total Non-Current Assets 0,0.00
TOTAL ASSETS 0,0.00
Liabilities & Shareholder Equity
Accounts Payable 0,0.00
Short Term Debt 0,0.00
Total Current Liabilities 0,0.00
Long Term Debt 0,0.00
Deferred Income Taxes 0,0.00
Other Non-Current Liabilities 0,0.00
Minority Interest 0,0.00
Total Non-Current Liabilities 0,0.00
Preferred Stock Equity 0,0.00
Common Stock Equity 0,0.00
Common Par 0,0.00
Additional Paid In Capital 0,0.00
Cumulative Translation Adjustment 0,0.00
Retained Earnings 0,0.00
Treasury Stock 0,0.00
Other Equity Adjustments 0,0.00
Total Capitalization 0,0.00
TOTAL EQUITY 0,0.00
TOTAL LIABILITIES & STOCK EQUITY 0,0.00
Total Common Shares Outstanding 0,0.00
Preferred Shares 0,0.00
Treasury Shares 0,0.00
Basic Weighted Shares Outstanding 0,0.00
Diluted Weighted Shares Outstanding 0,0.00
Number Of Employees 0,0.00
Number Of Part-Time Employees 0,0.00

TOTAL REVENUES

EBT Excluding Unusual Items

NET INCOME

Income Statement

M Y
Sales 0,0.00
Cost Of Sales 0,0.00
Gross Operating Profit 0,0.00
Selling, General, And Administrative Expenses 0,0.00
Research & Development 0,0.00
Operating Income Before D & A (EBITDA) 0,0.00
Depreciation & Amortization 0,0.00
Interest Income 0,0.00
Other Income - Net 0,0.00
Special Income / Charges 0,0.00
Total Income Before Interest Expenses (EBIT) 0,0.00
Interest Expense 0,0.00
Pre-Tax Income 0,0.00
Income Taxes 0,0.00
Minority Interest 0,0.00
Net Income From Continuing Operations 0,0.00
Net Income From Discontinued Operations 0,0.00
Net Income From Total Operations 0,0.00
Extraordinary Income/Losses 0,0.00
Income From Cum. Effect Of Acct. Change 0,0.00
Income From Tax Loss Carryforward 0,0.00
Other Gains / Losses 0,0.00
Total Net Income 0,0.00
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
0,0.00
Preferred Dividends 0,0.00
Net Income Available To Common 0,0.00
Basic EPS From Continuing Ops. 0,0.00
Basic EPS From Discontinued Ops. 0,0.00
Basic EPS From Total Operations 0,0.00
Basic EPS From Extraordinary Inc. 0,0.00
Basic EPS From Cum Effect Of Accounting Change 0,0.00
Basic EPS From Tax Loss Carryf'd. 0,0.00
Basic EPS From Other Gains (Losses) 0,0.00
Basic EPS, Total 0,0.00
Basic Normalized Net Income/Share 0,0.00
EPS From Continuing Ops. 0,0.00
EPS From Discontinued Ops 0,0.00
EPS From Total Ops. 0,0.00
EPS From Extraord. Inc. 0,0.00
EPS From Cum Effect of Accounting Change 0,0.00
EPS From Tax Loss Carfd. 0,0.00
EPS From Other Gains (L) 0,0.00
EPS, Total 0,0.00
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
0,0.00
Dividends Paid Per Share 0,0.00

CASH FROM OPERATIONS

CASH FROM INVESTING ACTIVITIES

CASH FROM FINANCING ACTIVITIES

Cash Flow Statement

M Y
Cash Flow From Operating Activities
Net Income (Loss) 0,0.00
Operating Gains/Losses 0,0.00
Gross Operating Profit 0,0.00
(Increase) Decrease In Receivables 0,0.00
(Increase) Decrease In Inventories 0,0.00
(Increase) Decrease In Other Current Assets 0,0.00
(Decrease) Increase In Other Current Liabilities 0,0.00
(Increase) Decrease In Other Working Capital 0,0.00
Other Non-Cash Items 0,0.00
Net Cash From Continuing Operations 0,0.00
Net Cash From Discontinued Operations 0,0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 0,0.00
Sale Of Property, Plant & Equipment 0,0.00
Cash Used For Investing Activities
Sale Of Short-Term Investments 0,0.00
Purchases Of Property, Plant & Equipment 0,0.00
Acquisitions 0,0.00
Purchases Of Short-Term Investments 0,0.00
Other Cash From Investing Activities 0,0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities 0,0.00
Issuance Of Debt 0,0.00
Cash Used For Financing Activities
Issuance Of Capital Stock 0,0.00
Repayment Of Long-Term Debt 0,0.00
Repurchase Of Capital Stock 0,0.00
Payment Of Cash Dividends 0,0.00
Other Financing Charges, Net 0,0.00
Net Cash From Financing Activities 0,0.00
Effect Of Exchange Rate Changes 0,0.00
Net Change In Cash & Cash Equivalents 0,0.00

Insider Information Summary

as of 12/31/1969
% Insiders - 54.99%
% Remaining Total Shares - 45.01%
Current 1 Month
Net Insider Transaction 13.50 K 13.50 K
Shares Bought 13.50 K 13.50 K
Shares Sold 0.00 0.00

Insider Activity

Transaction Date Insider/Title Transaction Type Market Value Shares Average Price Current Holdings

Recent Articles from TheStreet

Mark Cuban

Mark Cuban Takes On Walgreens, CVS, Amazon in Crowded Drug Space

The Dallas-based online pharmacy on Wednesday debuted its services with a goal to help shield consumers from inflated drug prices.

Cryptocurrency Bitcoin Lead

Why Does Bitcoin's Price Rise and Fall?

The cryptocurrency has been incredibly volatile.

Pepsi has a new doughnut. DBK

Pepsi Stock: Company Goes Full Thirst Trap With New Product

Gimmicks bring attention and PepsiCo wants to leverage its iconic brand with a new doughnut based on its iconic logo

Domino's The Noid Lead

Domino's CEO Shares Big Problem Facing Pizza Chains (And, It's Not The Noid)

A factor the pizza chain can't control may impact the return Domino's shares deliver to investors in 2022.

women entrepreneur sh

Top Tax Write-offs if You're Self-Employed

Whether you are a contractor or have your own small business, tax deductions for the self-employed can add up to substantial tax savings.

The Bears Are Starting to Attack the Stock Market, and It's Not Surprising

Cramer's Mad Money Recap 1/21: Microsoft, Tesla, Apple

Jim Cramer looks ahead to next week's earnings and sees more red as investors feel the impact of 'worthless IPOs and SPACs.'

Lawrence Summers has cautioned that pumping so much extra money into the US economy

Contradicting Yellen, Summers Says Inflation Won't Sink to 2% in 2022

Former Treasury Secretary is best known for saying there are fewer female mathematicians because of biological differences between the sexes.

Nayib Bukele Lead

El Salvador Buys The Dip, Acquires 410 Bitcoin

"El Salvador just bought 410 #bitcoin for only 15 million dollars," the country's president wrote on Twitter.